It is essential for early human life that immunological responses to developing embryos are 3 tightly regulated. An imbalance in the activation and regulation of the human complement 4 system occurs in pregnancy complications, such as pre-eclampsia and recurrent miscarriage. 5
The complement system is a part of the innate immune defense system, primarily involved in 3 anti-microbial defense, clearance of debris and immune regulation. This multi-lineage 4 enzymatic cascade functions as one of the earliest initiators of inflammation and a potent 5 inducer of adaptive immune responses. It may be initiated through the classical and lectin 6 pathways, driven by pattern-recognition (e.g. via C1q), or through the auto-activation of the 7 alternative pathway. All three pathways converge at the activation of C3 to C3a and C3b, with 8 the subsequent activation of C5 to C5a and C5b, and finally assembly of the pore-forming 9 membrane attack complex (MAC, C5b-C9). To avoid complement attack against self-tissue, 10 human surfaces express and/or recruit a number of membrane-bound and soluble regulators (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 3). 12 13 Increased complement activation is observed in certain autoimmune diseases, but also during 14 pregnancy (4-6). Thus, the role of complement dysregulation has emerged as an important 15 contributing factor to pregnancy complications and infertility, e.g. in pre-eclampsia and 16 recurring miscarriage (7-10). Understanding how the clearance-function of complement is 17 regulated in the context of tolerating the "semiallograft" embryo is therefore of paramount 18 importance (11). 19 20 In addition to the manifest role of complement in immune targeting and clearance, novel 21
functions have been revealed in recent years. Studies across multiple species have revealed 22 unexpected roles of complement molecules in fertilization, embryonic growth and 23 organogenesis (12). The liver is the main site for synthesis of complement components, 24 however, these novel findings have been driven by the detection of local cell-derived 25 complement factors and functional links to basic cellular homeostasis and metabolism (3, 9, 26 13-19). Furthermore, a number of animal models have revealed an effect of complement on 27 mouse embryo hatching rate, Xenopus organogenesis as well as on rodent neuronal 28 development (20-24). 29 30
While our understanding of local cellular complement activities is increasing, knowledge of 31 complement expression and localization at the very early stages of human life, i.e. the pre-32 implantation embryonic stage, is practically non-existing. To understand the impact of 33 complement on embryonic development, it is essential to investigate (i) potentially hazardous 34 embryonic targeting by maternal complement (complement clearance function), as well as (ii) 35 local embryonic production of complement components (cellular signaling and protection 36 against maternal complement attack). 37 38
In an effort to map the localization of complement molecules and understand the role of 39 complement activation in the early stages of human embryonic development, we here describe 40 the local cellular expression and surface deposition of complement components using single 41 cell RNA-transcriptomics and confocal microscopy of human non-fertilized oocytes, zygotes, 42 4-cell stage and 8-cell stage embryos. The current dogma in the field suggests that maternal 43 immune tolerance towards the conceptus is induced during and after implantation. However, 44 the findings presented here support a crucial role for innate immune mechanisms, such as 45 complement activation, already in the pre-implantation stage of human reproduction. 46 Furthermore, to the authors' knowledge, these studies are the first to show the expression of 47 multiple activating and regulatory complement components during human embryogenesis. Our 48 findings thus suggest that complement signaling may be essential for early human 49 development, as observed in other mammals. 50
Results

2
Embryos express complement regulators, activators and receptors 3
To understand the role of complement during early embryogenesis, we analyzed single-cell 4
transcriptomes from embryos at different developmental stages. Included were non-fertilized 5 oocytes, zygotes, 4-cell stage embryos and 8-cell stage embryos. Using single-cell tagged 6 reverse-transcription sequencing (STRT), 5 ' -Transcript Far Ends (TFEs) were analyzed as 7 described previously (25). Specifically, transcripts from the 5'-untranslated region (UTR) and 8 upstream are reliable templates for proteins, and these were used for the analysis along with a 9 number of reliable reads from the coding sequences (CDs). Three separate libraries were 10 generated comparing oocyte to zygote, oocyte to 4-cell stage and 4-cell to 8-cell stage. To 11 avoid batch-bias, these libraries were not batch corrected. We analyzed the presence of specific 12 complement-related TFEs found in each of the four stages ( Figure 1 Transcripts from a number of surface receptors, commonly found to mediate activation of 33 phagocytes and other immune cells, were also identified in the embryos. These include the 34 C5a-receptor 1 (C5aR1), the complement receptor 2 (CR2), and integrin beta chain-2 35 (ITGB2/CD18 -only alternative splice-form found), which combines with CD11b or CD11c, 36 forming the complement receptors CR3 and CR4, respectively. Transcripts of receptors for 37
C1q (linked to clearance of apoptotic material and tissue-remodeling), such as calreticulin and 38
C1q globular domain-binding protein (C1QBP, also known as gC1qR), were found at all 39 investigated stages. Finally, transcripts from adiponectin receptors 1 and 2 (ADIPOR1/2), 40 which are linked to cellular homeostasis and metabolism are also present in the early embryos. 41 42
No statistically significant increase in mRNA transcripts were identified from oocyte to the 43 fertilized stages. The timing of active transcription is thus likely to be during oogenesis (27). 44
Transcripts correlating to known alternative splice-forms (observed for ADIPOR1 and 2,  45  C1QBP, C3, C4BPB, CD55, CD59, CR2, and ITGB2) may either reflect alternative protein  46 functions, or partial breakdown of transcripts. Changes over time in the ratio between 47 3'UTR/degraded reads and 5'-UTR-proximal reads, may indicate an active downregulation of 48 genes. By comparing the 3'/5'-ratios at oocyte versus 4-cell stage, we observed an increased 49 ratio for ADIPOR2, C1QBP, C5 and CD55, suggesting their gradually increasing degradation. 50
In contrast, a decreased ratio was observed for C3, C5aR1 and MASP2, suggesting their active 1 transcription (data not shown). 2 3
In addition to the above-mentioned verified non-degraded transcripts, mRNA transcripts from 4 several other complement genes were also identified in at least one of the four investigated 5 stages. The lack of TFEs at the 5' UTR proximal region of these reads may reflect partial 6 breakdown of maternal transcripts, existence of promiscuous (zygotic) RNAs or novel isoforms 7 (28, 29). Further validation is needed to determine if these transcripts produce functional 8 protein at this developmental stage. These genes are highlighted in the Supplementary Table  9 S1. A number of additional complement-related genes were investigated; however, no 10 expression was detected. These are listed in Supplementary Figure 2B ) shows a clear deposition on the cellular membranes. A disperse 24 staining is also observed on the surface of the zona pellucida (ZP). The presence of C3b/iC3b 25 on the cell membranes shows that complement activation targets human embryos. C3d is the 26 final breakdown product of C3-inactivation and remains covalently bound to a surface long 27 after activation has taken place. We therefore next analyzed the presence of C3d on the 28 embryos ( Figure 2C ). We observe clear staining for C3d on the membranes of the embryonic 29 cells. This shows that a large part of C3b on the embryonic surface has become degraded to 30 C3d, indicating efficient control. In contrast to the C3b/iC3b-staining, we observed more 31 staining for C3d on the ZP. However, variation between embryos was observed. Following 32 deposition of complement C3b and generation of the C5 convertase, the cascade leads to the 33 activation of C5 on the target surface. We therefore investigated the presence of C5 on the 34 embryonic surface, using a polyclonal antibody recognizing both cleaved and non-cleaved 35 forms of C5. Here we observed a very strong staining on the surface of the ZP, but not on the 36 surface of the cleavage stage embryo blastomeres ( Figure 2D ). Despite our RNA-seq data 37
showing cellular expression of both C3 and C5 (Figure 1) The expression of the three membrane regulators showed varying intensity, as expected from 49 the gene expression data (Figure 1 ). In the investigated cleavage stage embryos, we observed 50 strong staining for CD55 and CD59, but not for CD46. Interestingly, CD55 and to a lesser 1 degree CD59, displayed a specific non-uniform localization. Both molecules are observed on 2 the blastomere membranes. However, a stronger signal is observed specifically at the cellular 3 junctions. While the majority of signal for CD55 is seen at the cell-cell interfaces, CD59 is 4 found more abundantly dispersed throughout the entire cell surface. This specific pattern of 5 CD59 expression seems to be consistent through all the early developmental stages (zygote to 6 8-cell stage, see supplementary Figure S1 ). As expected, no specific signal was observed for 7 any of these molecules in the ZP. 8 9
In addition to the presence of membrane bound regulators, the ability to recruit soluble 10 complement regulators is crucial for protection of viable cells against autologous complement 11 attack (30-32). We therefore examined, whether embryos have bound the fluid phase 12 complement regulators C4bp and factor H ( Figure 4 ). 13 14
C4bp and factor H are recruited to human surfaces immediately following complement 15 activation, i.e. after deposition of C4b and C3b, respectively. Our data show a clear deposition 16 of both C4bp and factor H on the cell membranes of the cleavage stage embryo blastomeres. 17
In addition to the cellular localization of factor H, a strong staining was also observed in the 18 ZP. This was not observed for C4bp. The binding of factor H but not of C4bp to the surface of 19 the ZP suggests that a major part of complement activation on the ZP protein matrix ( Figure 2 ) 20 is driven by alternative pathway activation, which does not involve C4 cleavage. Therefore, 21
only factor H, and not C4bp would be recruited to this surface. 22
Complement is a very potent mediator of inflammation, and untimely activation on self-3 surfaces contributes to a great number of pathologies, such as atypical hemolytic uremic 4 syndrome, paroxysmal nocturnal hemoglobinuria, pregnancy disorders and kidney diseases 5 (11, 33, 34). An understanding of the precise targeting of complement activation in various 6 physiological settings is therefore of great importance. Animal models have been a great tool 7 in understanding these processes. However, it is well established that variation exist between 8 the human complement system and that of other species, such as mice (35-37). The continued 9 investigation of human complement function is therefore crucial. 10 11
The current study is the first full analysis of the expression and localization of complement 12 activation molecules and their regulators in human pre-implantation embryos ( Figure 5 ). We 13
show that complement targets the embryonic surfaces and observe deposition of complement 14 activators, such as C1q, C3 and C5. later development (4-7, 9-11). Our data provide a novel, much earlier, mechanism, whereby a 6 faulty or insufficient complement regulation may predispose to pregnancy disorders and 7 miscarriage. 8 9
The expression of CD55 and CD59 throughout the investigated period of embryogenesis, and 10 CD46 at certain stages, may be important for embryo survival. However, attempts of stem-cell 11 transplantation show the importance of soluble regulators for cell survival as well (30, 31). Our 12 data reveal presence of clusterin and factor I mRNA, and deposition of C4bp and factor H on 13 the cleavage stage embryos. The inhibitory effects of these molecules were substantiated by 14 our staining for C3-degradation products. Importantly, only the non-degraded C3b will lead to 15 continuation of the complement cascade and formation of the C5 activating convertase. No 16 staining was observed for C5 on the blastomere membranes, thus showing that the kinetics of 17 the complement regulation favor degradation of C3b deposited on the cell surfaces. However, 18 on the ZP, the lack of membrane regulators may favor a different outcome. The presence of 19 factor H, but not of C4bp, on the surface of the ZP suggests that the majority of complement 20 activation against the ZP protein matrix is a result of alternative pathway activation, which 21 does not involve C4 cleavage. A strong C5 deposition was observed on the ZP, indicating that 22 this layer absorbs the most intense complement attack. Though our staining for C3d revealed 23 that a lot of the C3b deposited has become degraded, the kinetics of C3b-degradation versus 24 C5-convertase formation has still favored C5 activation. Given the stronger deposition of 25 complement activation products, a function of the ZP may be to divert complement from the 26 cell membranes, and act as a protective layer for the developing embryo also in this respect. 27
The role of factor H as the main inhibitor of complement activation against the ZP, highlights 28 the potentially detrimental impact of factor H deficiencies on reproduction. Still, while we here 29 observe potentially harmful pro-inflammatory stimuli in response the pre-implantation 30 embryo, the impact on pregnancy outcome may be less clear. Local inflammatory processes 31 are crucial for decidualization of the endometrium following implantation and in establishing 32 immune tolerance towards the developing conceptus (50 Complement in human pre-implantation embryos: attack and defense
